GHK-Cu / KPV is a 60 mg vial of 50 mg GHK-Cu and 10 mg KPV marketed for skin and inflammation.
A fixed-ratio blend requires component-aware arithmetic. Vial composition is kept separate from target amounts so component strengths are never presented as dose suggestions.
Choose the exact vial variant. The Advanced Blend workspace prefills each component and calculates every component concentration from one shared prepared volume.
Each listed number identifies how much of one component is present in the full vial. It does not establish how much of the blend to draw or how often.
Reported protocols describe how sources reconstitute and draw this vial as a whole, each tied to where it was said.
Each peptide's own page reports what studies and guides describe for it alone; the leading rows are repeated below.
The ratio is fixed by the vial, so a draw sized for one component sets the amount of all the others at the same time.
GHK-Cu / KPV Blend is 2 peptides in one vial. Each profile below is PubChem's record for that peptide, read from its own library page; the vial amount is what the label states for this blend, not an amount per draw.
GHK-Cu50 mg per vial
KPV10 mg per vial
What published studies and recent community write-ups report about amounts, timing and course length. 3 community-reported rows, each linked to its source. These are descriptions of what others report, not instructions, and nothing here is medical advice.
| Context | Dose | Frequency | Route | Course | Source |
|---|---|---|---|---|---|
| Community-reported3 rows | |||||
| Community buying guide: standard and higher daily draws from the 60 mg vial | 1 mg GHK-Cu with 250 mcg KPV per day (standard) or 2 mg GHK-Cu with 500 mcg KPV per day | Once daily; a 5-days-on, 2-off pattern is also tabulated | Injection (the guide calls injectable GHK-Cu research-grade only) | 8-12 weeks described as the standard cycle; one 60 mg vial lasts about 6 weeks at the standard draw and about 3 weeks at the higher oneNot described | Community resource2026 |
| The guide counts 2-4 vials for a 12-week cycle and points out that at the standard draw a vial outlasts the 28-day window it gives for reconstituted material, so it describes staged reconstitution as common practice. It explains the 5:1 ratio as reflecting KPV's activity at lower amounts rather than equal-mass mixing, says free GHK sold as GHK-Cu is the most common substitution and asks for copper-binding verification on the certificate. It is a buying guide that ranks vendors, so it is commercial. | |||||
| Forum thread: members combining 50 mg GHK-Cu and 10 mg KPV in one vial | 2 mg GHK-Cu per draw from 50 mg GHK-Cu plus 10 mg KPV in 3 mL of bacteriostatic water (one member); 2 mg GHK-Cu with 400 mcg KPV per 10-12 units from a home-made 20 mg/mL and 4 mg/mL mix (another) | Once daily | Subcutaneous | 6 weeks on (first member); 12 weeks on (second)3 weeks off; 4-6 weeks off | Community resource2026 |
| These are self-reports on a GLP-1 forum from people who reconstitute separate GHK-Cu and KPV vials into one sterile vial to arrive at the same 50/10 ratio the blend sells at, saying the KPV reduces GHK-Cu injection-site reactions. One couple ran KPV alone first, titrating from 200 to 400-500 mcg over about four weeks, then added GHK-Cu at 2 mg; a member with 100 mg GHK-Cu vials uses 6 mL of water to soften welts and stinging, and zinc supplementation is mentioned to balance copper. Anecdote throughout, with no control for the GLP-1 drugs the posters also use. | |||||
| Vendor page: reconstitution volumes and handling for the 50/10 vial | Daily or twice daily in in-vivo work, amount not stated; 3 mL of bacteriostatic water gives 16.67 mg/mL GHK-Cu and 3.33 mg/mL KPV (20 mg/mL total), 6 mL gives 10 mg/mL total | Daily or twice daily (the vendor's description of in-vivo protocols) | Subcutaneous or topical in the animal models the vendor describes | Use within 30 days of reconstitutionNot described | Community resource2026 |
| The vendor sells the 60 mg vial and gives the mixing arithmetic without a human dose: water down the inside wall, swirl, expect a blue to violet solution, and treat a shift to green or brown or any cloudiness as degradation. It cites short plasma half-lives for both peptides (about 30-60 minutes for GHK-Cu) as the reason for daily or twice-daily frequency, warns against EDTA and other chelators that strip the copper, and says the combination data remain preclinical while describing the pairing's rationale as mechanistic complementarity. Vendor claims throughout. | |||||
Plus 6 community resources (dosing guides, forum threads and vendor write-ups), reported above but not linked.
What sources report for each peptide on its own. In GHK-Cu / KPV Blend the vial ratio fixes the proportions, so one draw delivers every component at once and none can be raised without the others. The first rows from each component's table are shown here; its page carries the rest, each linked to its source. Descriptions of what others report, not instructions.
These fields come from the existing picker, blend catalog and observed presentation data. They are identity and availability context, not evidence of effectiveness.
GHK-Cu / KPV is a 60 mg vial of 50 mg GHK-Cu and 10 mg KPV marketed for skin and inflammation. It is the two-peptide subset of KLOW, sold at this 5:1 ratio by several vendors (one as KG60), while another vendor's version, Copper Calm, holds 50 mg GHK-Cu with 20 mg KPV, and one vendor warns that both ratios are sold under the same names. No published work has examined the two peptides together, so the evidence sits on the component pages and the rows below are a buying guide, a forum thread and a vendor page describing how the 60 mg vial is mixed and drawn.
Fixed-ratio blend reference
Kept separate from single-peptide evidence and terminology.
Structured review queued
No evidence level is assigned until references and study models are reviewed.
Advanced Blend workspace
Calculator access performs arithmetic; it does not establish an amount or protocol.
No reviewed observation on file
The vial label remains the authoritative source for any calculation.
Each number is the vial amount for that component. It is not a per-draw amount.
2 curated references, each with its journal, year and study model, plus 6 community resources reported but not linked.